In the current review, special attention is paid to the bipolar risk gene, etratricopeptide repeat and ankyrin repeat containing 1 (TRANK1) and its potential interaction with the gut microbiota, which is speculated to impair the integrity of blood‐brain barrier (BBB) and facilitates the neuroinflammation in BD. This evidence concerns the gene TRANK1 and Behcet disease.